Skip to main content
Equibles
BDX logo

BDX · Becton Dickinson & Co

Track BDX — free

Use BDX with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$184.74 -2.88 (-1.54%) At close · Sep 4
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$50.32B
Shares
272.39M

BDX metrics

92 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$184.74
Market cap
$50.32B

Price action

19 metrics
Price change (1W)
-2.5%
Price change (30D)
+2.8%
Price change (3M)
+22.2%
Price change (6M)
+10.5%
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
27.7%
Beta
0.3
RSI (14D)
57.5
Price vs SMA 50
+8.7%
Price vs SMA 200
—
Avg volume (3M)
2.11M
Relative volume
0.7
Average dollar volume
$342.71M

Company

3 metrics
Sector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
272.39M

Valuation

12 metrics
P / E (TTM)
92.3
Trailing earnings · reciprocal yield 1.1%
PEG ratio
—
EV / revenue
3.0×
reciprocal yield 33.7%
EV / EBITDA
13.9×
reciprocal yield 7.2%
EV / EBIT
28.7×
reciprocal yield 3.5%
P / sales
2.2×
reciprocal yield 44.5%
P / book
2.1
reciprocal yield 48.5%
FCF yield
6.4%
TTM · current market cap
Buyback yield
5.0%
P / FCF
15.7
reciprocal yield 6.4%
P / operating cash flow
12.7
reciprocal yield 7.9%
Earnings yield
1.9%

Historical valuation

8 metrics
P / E historical average (3Y)
43.8×
reciprocal yield 2.3%
P / E historical average (5Y)
43.3×
reciprocal yield 2.3%
EV / revenue historical average (3Y)
3.7×
reciprocal yield 27.0%
EV / revenue historical average (5Y)
4.0×
reciprocal yield 24.8%
EV / EBIT historical average (3Y)
33.4×
reciprocal yield 3.0%
EV / EBIT historical average (5Y)
34.7×
reciprocal yield 2.9%
EV / EBITDA historical average (3Y)
16.2×
reciprocal yield 6.2%
EV / EBITDA historical average (5Y)
17.5×
reciprocal yield 5.7%

Dividends & buybacks

7 metrics
Dividend yield
1.8%
Trailing 12 months
Payout ratio
124.5%
Shareholder yield
7.3%
Dividend / share (TTM)
$3.39
Dividend growth YoY
+34.8%
Dividend growth streak
5
Last ex-dividend
2026-06-09

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
—
Operating margin
10.3%
Trailing 12 months
Net margin
4.2%
Gross profit (TTM)
$7.58B
Operating profit (TTM)
$2.31B
Net income (TTM)
$941.00M
Trailing 12 months
Diluted EPS (TTM)
$2.00
FCF margin
14.3%
Effective tax rate
12.7%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$89.64

Growth

11 metrics
Revenue growth YoY
+5.4%
Year over year
Net income growth YoY
-34.3%
Revenue (TTM)
$22.41B
Trailing 12 months
EPS growth YoY
-31.5%
Shares change YoY
-4.2%
Year over year · fewer shares
Revenue CAGR (3Y)
+5.0%
Revenue CAGR (5Y)
+6.3%
EPS CAGR (3Y)
-0.3%
EPS CAGR (5Y)
+16.5%
FCF CAGR (3Y)
+21.2%
FCF CAGR (5Y)
-0.7%

Quality

14 metrics
Return on equity
3.9%
Return on assets
1.9%
Debt / equity
0.7
Current ratio
0.9
EBITDA (TTM)
$4.77B
Free cash flow (TTM)
$3.20B
Quick ratio
0.5
Interest coverage
3.9
Net debt / EBITDA
3.4
Return on invested capital
5.0%
Trailing 12 months
Net cash
−$16.10B
Latest balance sheet
Cash & equivalents
$708.00M
Total assets
$50.73B
Total debt
$16.81B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$3.96B
Capital expenditures (TTM)
$753.00M
R&D (TTM)
$1.27B
SG&A (TTM)
$5.55B
Stock compensation (TTM)
$283.00M
R&D / revenue
5.7%
Stock compensation / revenue
1.3%

Ownership (13F)

3 metrics
13F filers
1,445
13F filer change QoQ
-38
Institutional ownership
97.4%

Short interest

3 metrics
Short interest
3.4%
Latest settlement · 4.8 days to cover
Days to cover
4.8d
Short-squeeze score
59 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$1.59M
Insider-sentiment score
51 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 10795 CUSIP 075887109 13F (30d) 624 filings 594 filers Visit website Investor relations